148 related articles for article (PubMed ID: 7014602)
1. Blunted pancreatic polypeptide responses in children with obesity of Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Cataland S; Sotos J
J Clin Endocrinol Metab; 1981 Jun; 52(6):1264-6. PubMed ID: 7014602
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Cataland S; Dixon K
J Clin Endocrinol Metab; 1983 Nov; 57(5):1074-80. PubMed ID: 6352724
[TBL] [Abstract][Full Text] [Related]
3. Protein meal-stimulated pancreatic polypeptide secretion in Prader-Willi syndrome of adults.
Tomita T; Greeley G; Watt L; Doull V; Chance R
Pancreas; 1989; 4(4):395-400. PubMed ID: 2668931
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
Glaser B; Zoghlin G; Pienta K; Vinik AI
Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
[TBL] [Abstract][Full Text] [Related]
6. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
[TBL] [Abstract][Full Text] [Related]
7. Short-term infusion of pancreatic polypeptide: effect on children with Prader-Willi syndrome.
Zipf WB; O'Dorisio TM; Berntson GG
Am J Clin Nutr; 1990 Feb; 51(2):162-6. PubMed ID: 2407095
[TBL] [Abstract][Full Text] [Related]
8. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
9. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
Osei K; Falko JM; O'Dorisio TM; Fields PG; Bossetti B
J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
[TBL] [Abstract][Full Text] [Related]
10. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome.
Berntson GG; Zipf WB; O'Dorisio TM; Hoffman JA; Chance RE
Peptides; 1993; 14(3):497-503. PubMed ID: 8332550
[TBL] [Abstract][Full Text] [Related]
12. Peptide YY, cholecystokinin, insulin and ghrelin response to meal did not change, but mean serum levels of insulin is reduced in children with Prader-Willi syndrome.
Paik KH; Jin DK; Lee KH; Armstrong L; Lee JE; Oh YJ; Kim S; Kwon EK; Choe YH
J Korean Med Sci; 2007 Jun; 22(3):436-41. PubMed ID: 17596650
[TBL] [Abstract][Full Text] [Related]
13. Diurnal GIP, PP and insulin levels in morbid obesity before and after stapled gastric partitioning with gastro-gastrostomy.
Amland PF; Jorde R; Giercksky KE; Burhol PG
Int J Obes; 1984; 8(2):117-22. PubMed ID: 6373640
[TBL] [Abstract][Full Text] [Related]
14. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
Service FJ; Rizza RA; Westland RE; Hall LD; Gerich JE; Go VL
J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
[TBL] [Abstract][Full Text] [Related]
15. A lesser postprandial suppression of plasma ghrelin in Prader-Willi syndrome is associated with low fasting and a blunted postprandial PYY response.
Giménez-Palop O; Giménez-Pérez G; Mauricio D; González-Clemente JM; Potau N; Berlanga E; Trallero R; Laferrère B; Caixàs A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):198-204. PubMed ID: 17223988
[TBL] [Abstract][Full Text] [Related]
16. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.
Stock S; Leichner P; Wong AC; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP
J Clin Endocrinol Metab; 2005 Apr; 90(4):2161-8. PubMed ID: 15657373
[TBL] [Abstract][Full Text] [Related]
17. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
Sze L; Purtell L; Jenkins A; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1314-9. PubMed ID: 21632815
[TBL] [Abstract][Full Text] [Related]
18. Interdigestive cycling and post-prandial release of pancreatic polypeptide in severe obesity.
Pieramico O; Malfertheiner P; Nelson DK; Glasbrenner B; Ditschuneit H
Int J Obes; 1990 Dec; 14(12):1005-11. PubMed ID: 2086493
[TBL] [Abstract][Full Text] [Related]
19. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome.
Paik KH; Choe YH; Park WH; Oh YJ; Kim AH; Chu SH; Kim SW; Kwon EK; Han SJ; Shon WY; Jin DK
J Clin Endocrinol Metab; 2006 May; 91(5):1876-81. PubMed ID: 16507634
[TBL] [Abstract][Full Text] [Related]
20. Effects of physical training on insulin, connecting peptide (C-peptide), gastric inhibitory polypeptide (GIP) and pancreatic polypeptide (PP) levels in obese subjects.
Krotkiewski M; Björntorp P; Holm G; Marks V; Morgan L; Smith U; Feurle GE
Int J Obes; 1984; 8(3):193-9. PubMed ID: 6378815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
